Lack of responses to a beta3-adrenergic agonist in lipoatrophic A-ZIP/F-1 mice.

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Diabetes

• Publication date

  2000-11-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.2337/DIABETES.49.11.1910PMID 11078459
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Surgical implantation of adipose tissue reverses diabetes in lipoatrophic mice.

  2000cited by this paper
• Hormones: Leptin and diabetes in lipoatrophic mice

  2000cited by this paper
• Mechanism of Insulin Resistance in A-ZIP/F-1 Fatless Mice*

  2000cited by this paper
• The fourth dimension of life: fractal geometry and allometric scaling of organisms.

  1999cited by this paper
• Development of beta 3-adrenoceptor agonists for the treatment of obesity and diabetes--an update.

  1999cited by this paper
• Characterization of beta-adrenoceptor mediated smooth muscle relaxation and the detection of mRNA for beta1-, beta2- and beta3-adrenoceptors in rat ileum.

  1999cited by this paper
• Torpor in mice is induced by both leptin-dependent and -independent mechanisms.

  1999cited by this paper
• Alternative splicing generates two isoforms of the β3‐adrenoceptor which are differentially expressed in mouse tissues

  1999cited by this paper
• Beta-3 adrenergic receptor agonists cause an increase in gastrointestinal transit time in wild-type mice, but not in mice lacking the beta-3 adrenergic receptor.

  1998cited by this paper
• Life without white fat: a transgenic mouse.

  1998cited by this paper
• Insulin resistance and diabetes mellitus in transgenic mice expressing nuclear SREBP-1c in adipose tissue: model for congenital generalized lipodystrophy.

  1998cited by this paper
• Mice expressing human but not murine beta3-adrenergic receptors under the control of human gene regulatory elements.

  1998cited by this paper
• Increase in insulin action and fat oxidation after treatment with CL 316,243, a highly selective beta3-adrenoceptor agonist in humans.

  1998cited by this paper
• CL-316,243, a β3-Specific Adrenoceptor Agonist, Enhances Insulin-Stimulated Glucose Disposal in Nonobese Rats

  1997cited by this paper
• Uncoupling Protein-3 Is a Mediator of Thermogenesis Regulated by Thyroid Hormone, β3-Adrenergic Agonists, and Leptin*

  1997cited by this paper
• Brown adipose tissue, beta 3-adrenergic receptors, and obesity.

  1997cited by this paper
• Troglitazone action is independent of adipose tissue.

  1997cited by this paper
• Beta3-adrenergic receptors on white and brown adipocytes mediate beta3-selective agonist-induced effects on energy expenditure, insulin secretion, and food intake. A study using transgenic and gene knockout mice.

  1997cited by this paper
• ANTI‐OBESITY AND ANTI‐DIABETIC EFFECTS OF MAZINDOL IN YELLOW KK MICE: ITS ACTIVATING EFFECT ON BROWN ADIPOSE TISSUE THERMOGENESIS

  1996cited by this paper
• Targeted Disruption of the β3-Adrenergic Receptor Gene *

  1995cited by this paper
• Is the "atypical" beta-receptor in the rat stomach fundus the rat beta 3 receptor?

  1995cited by this paper
• Inhibitory effects of SR 58611A on canine colonic motility: evidence for a role of β3‐adrenoceptors

  1995cited by this paper
• Effect of CL 316,243, a novel beta 3-adrenoceptor agonist, on insulin secretion in perfused mouse pancreas.

  1994cited by this paper
• Anti-obesity and anti-diabetic effects of CL 316,243, a highly specific beta 3-adrenoceptor agonist, in yellow KK mice.

  1994cited by this paper
• Anti-obesity effect of CL 316,243, a highly specific beta 3-adrenoceptor agonist, in mice with monosodium-L-glutamate-induced obesity.

  1994cited by this paper
• Effect of CL-316,243, a thermogenic beta 3-agonist, on energy balance and brown and white adipose tissues in rats.

  1994cited by this paper
• Beta 3 and atypical beta-adrenoceptors.

  1993cited by this paper
• Development of obesity in transgenic mice after genetic ablation of brown adipose tissue

  1993cited by this paper
• Tissue distribution of beta 3-adrenergic receptor mRNA in man.

  1993cited by this paper
• Targeted expression of a toxin gene to adipose tissue: transgenic mice resistant to obesity.

  1993cited by this paper
• Disodium (R,R)-5-[2-[[2-(3-chlorophenyl)-2-hydroxyethyl]-amino] propyl]-1,3-benzodioxole-2,2-dicarboxylate (CL 316,243). A potent beta-adrenergic agonist virtually specific for beta 3 receptors. A promising antidiabetic and antiobesity agent.

  1992cited by this paper
• Regulation of the level of uncoupling protein in brown adipose tissue by insulin requires the mediation of the sympathetic nervous system

  1990cited by this paper
• Molecular characterization of the human beta 3-adrenergic receptor.

  1989cited by this paper
• Differences between the effects of noradrenaline and the beta-adrenoceptor agonist BRL 28410 in brown adipose tissue and hind limb of the anaesthetized rat.

  1986cited by this paper

• Neither rats nor mice have a broad thermoneutral zone: implications for physiological studies

  2026cites this paper
• Epac1 mediates thermogenesis and lipolysis in white adipose tissue via the p38γ-NFAT5 axis in a PKA-independent manner

  2025cites this paper
• Lipodystrophy in methylmalonic acidemia associated with elevated FGF21 and abnormal methylmalonylation

  2024influential citation
• A key role for P2RX5 in brown adipocyte differentiation and energy homeostasis

  2024cites this paper
• Reassessing Human Adipose Tissue.

  2022cites this paper
• The glucose lowering effects of CL 316,243 dissipate with repeated use and are rescued bycilostamide

  2022cites this paper
• Chemogenetic approaches to identify metabolically important GPCR signaling pathways: Therapeutic implications

  2021influential citation
• Repurposing beta-3 adrenergic receptor agonists for Alzheimer’s disease: beneficial effects in a mouse model

  2021cites this paper
• Combining a β3 adrenergic receptor agonist with alpha‐lipoic acid reduces inflammation in male mice with diet‐induced obesity

  2021cites this paper
• Cinnamomum cassia extract promotes thermogenesis during exposure to cold via activation of brown adipose tissue.

  2020cites this paper
• Repurposing beta3-adrenergic receptor agonists for Alzheimer’s disease: Beneficial effects on recognition memory and amyloid pathology in a mouse model

  2020cites this paper
• Anti-Lipolysis Induced by Insulin in Diverse Pathophysiologic Conditions of Adipose Tissue

  2020cites this paper
• Chronic mirabegron treatment increases human brown fat, HDL cholesterol, and insulin sensitivity.

  2020cites this paper
• Use of DREADD Technology to Identify Novel Targets for Antidiabetic Drugs.

  2020cites this paper
• Anti-Lipolysis Induced by Insulin in Diverse Pathophysiologic Conditions of Adipose Tissue Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy

  2020cites this paper
• Selective activation of Gs signaling in adipocytes causes striking metabolic improvements in mice

  2019cites this paper
• Regulation of Human Adipose Tissue Activation, Gallbladder Size, and Bile Acid Metabolism by a β3-Adrenergic Receptor Agonist

  2018cites this paper
• Lipolysis Triggers a Systemic Insulin Response Essential for Efficient Energy Replenishment of Activated Brown Adipose Tissue in Mice.

  2018cites this paper
• The role of the brown adipose tissue in β3-adrenergic receptor activation-induced sleep, metabolic and feeding responses

  2017cites this paper
• Anti-obesity and metabolic efficacy of the β3-adrenergic agonist, CL316243, in mice at thermoneutrality compared to 22°C

  2015cites this paper
• Sustained Brown Fat Stimulation and Insulin Sensitization by a Humanized Bispecific Antibody Agonist for Fibroblast Growth Factor Receptor 1/βKlotho Complex

  2015cites this paper
• Effect of Intermittent Cold Exposure on Brown Fat Activation, Obesity, and Energy Homeostasis in Mice

  2014cites this paper
• PACAP is essential for the adaptive thermogenic response of brown adipose tissue to cold exposure.

  2014cites this paper
• The Chemical Uncoupler 2,4-Dinitrophenol (DNP) Protects against Diet-induced Obesity and Improves Energy Homeostasis in Mice at Thermoneutrality*

  2014cites this paper
• Contrasts between the effects of zinc-α2-glycoprotein, a putative β3/2-adrenoceptor agonist and the β3/2-adrenoceptor agonist BRL35135 in C57Bl/6 (ob/ob) mice.

  2013cites this paper
• Detection of thermogenesis in rodents in response to anti-obesity drugs and genetic modification

  2013cites this paper
• Disruption of Hypoxia-Inducible Factor 1 in Adipocytes Improves Insulin Sensitivity and Decreases Adiposity in High-Fat Diet–Fed Mice

  2011cites this paper
• Dietary Fiber/Carnitine, Diacylglycerol, and Low Glycemic Index Starch Effects on Obesity and Triglyceride Rich Lipoprotein Metabolsim in Dogs

  2011cites this paper
• Thermogenesis and related metabolic targets in anti-diabetic therapy.

  2011cites this paper
• Targeted deletion of one or two copies of the G protein β subunit Gβ5 gene has distinct effects on body weight and behavior in mice

  2011cites this paper
• Suppression of the C/EBP family of transcription factors in adipose tissue causes lipodystrophy.

  2011cites this paper
• Enhanced metabolic flexibility associated with elevated adiponectin levels.

  2010cites this paper
• GPR40 is partially required for insulin secretion following activation of beta3-adrenergic receptors.

  2010cites this paper
• G(s)alpha deficiency in adipose tissue leads to a lean phenotype with divergent effects on cold tolerance and diet-induced thermogenesis.

  2010influential citation
• Disturbances in core body temperature in RIP140-null mice

  2009cites this paper
• Effect of leptin infusion on insulin sensitivity and lipid metabolism in diet-induced lipodystrophy model mice

  2008cites this paper
• Lipids in Health and Disease

  2008cites this paper
• A model for obesity and gigantism due to disruption of the Ankrd26 gene

  2008cites this paper
• The discovery of drugs for obesity, the metabolic effects of leptin and variable receptor pharmacology: perspectives from β3-adrenoceptor agonists

  2008cites this paper
• Lipids in Health and Disease

  2008cites this paper
• Vagal afferents mediate the feeding response to mercaptoacetate but not to the beta (3) adrenergic receptor agonist CL 316,243.

  2007cites this paper
• Disruption of the Arnt gene in endothelial cells causes hepatic vascular defects and partial embryonic lethality in mice

  2006cites this paper
• Effect of adipocyte beta3-adrenergic receptor activation on the type 2 diabetic MKR mice.

  2006cites this paper
• The alternative stimulatory G protein alpha-subunit XLalphas is a critical regulator of energy and glucose metabolism and sympathetic nerve activity in adult mice.

  2006cites this paper
• The Alternative Stimulatory G Protein α-Subunit XLαs Is a Critical Regulator of Energy and Glucose Metabolism and Sympathetic Nerve Activity in Adult Mice*

  2006cites this paper
• Obesity drugs and their targets: correlation of mouse knockout phenotypes with drug effects in vivo

  2006cites this paper
• Mercaptoacetate fails to block the feeding-inhibitory effect of the beta3-adrenergic receptor agonist CGP 12177A.

  2006cites this paper
• Alterations in regulation of energy homeostasis in cyclic nucleotide phosphodiesterase 3B-null mice.

  2006cites this paper
• Transgenic animal models for the study of adipose tissue biology.

  2005cites this paper
• Leptin improves insulin resistance and hyperglycemia in a mouse model of type 2 diabetes.

  2005cites this paper
• Effects of Wnt Signaling on Brown Adipocyte Differentiation and Metabolism Mediated by PGC-1α

  2005cites this paper
• Fat apoptosis through targeted activation of caspase 8: a new mouse model of inducible and reversible lipoatrophy

  2005cites this paper
• Muscle-specific overexpression of CD36 reverses the insulin resistance and diabetes of MKR mice.

  2004cites this paper
• Fatty acid oxidation and control of food intake.

  2004cites this paper
• White adipose tissue contributes to UCP1-independent thermogenesis.

  2003cites this paper
• Liver Peroxisome Proliferator-activated Receptor γ Contributes to Hepatic Steatosis, Triglyceride Clearance, and Regulation of Body Fat Mass*

  2003cites this paper
• Seasonal Changes in Adiposity: the Roles of the Photoperiod, Melatonin and Other Hormones, and Sympathetic Nervous System

  2002cites this paper
• Understanding adipose tissue development from transgenic animal models.

  2002cites this paper
• Brown adipose tissue-specific insulin receptor knockout shows diabetic phenotype without insulin resistance.

  2001cites this paper
• The beta 3-adrenergic system and beta 3-adrenergic agonists.

  2001cites this paper
• The β3-Adrenergic System and β3-Adrenergic Agonists

  2001cites this paper
• Perilipin ablation results in a lean mouse with aberrant adipocyte lipolysis, enhanced leptin production, and resistance to diet-induced obesity

  2001cites this paper
• Adipose tissue is required for the antidiabetic, but not for the hypolipidemic, effect of thiazolidinediones.

  2000cites this paper